Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Shukra Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₹67.6

2024-10-29

Market Capitalization

₹108.7 M

2024-10-29

Revenue

₹567.3 M

FY, 2026

CreditSafe Score

?
Score changed on Jul 22, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025FY, 2026
Revenue15.6M13.7M44.5M112.0M204.9M588.3M745.7M325.9M567.3M
Cost of goods sold9.5M9.9M30.0M27.7M103.5M453.2M444.9M81.1M158.5M
Gross profit43.9M46.7M88.4M87.4M101.9M146.5M323.4M272.0M454.6M
Gross profit margin, %341.2%198.8%78.0%49.7%24.9%43.4%83.5%80.1%
Operating expense total27.8M30.2M73.0M69.8M72.5M81.5M106.8M117.5M121.4M
Depreciation and amortization7.4M9.6M14.8M14.7M16.6M18.4M20.5M30.0M34.4M
EBITDA16.2M16.5M15.4M17.5M29.3M65.0M216.6M154.6M333.2M
EBITDA margin, %120.5%34.6%15.7%14.3%11.0%29.0%47.4%58.7%
EBIT9.8M7.2M1.6M844.0K12.7M46.6M196.1M124.5M298.8M
EBIT margin, %52.6%3.7%0.8%6.2%7.9%26.3%38.2%52.7%
Interest income53.0K51.0K85.0K467.0K314.0K639.0K5.6M14.8M
Interest expense403.0K6.0K21.0K333.0K2.9M2.8M2.9M5.9M10.9M
Pre tax profit9.5M7.2M1.7M978.0K10.2M44.4M198.8M133.4M287.9M
Income tax expense4.2M2.6M1.4M(903.0K)2.7M352.0K13.5M37.6M67.3M
Net Income5.3M4.6M356.0K1.9M7.5M44.1M185.4M95.8M220.6M

Footer menu